San Diego, CA (PRWEB) February 21, 2017 GB HealthWatch, a digital health and nutritional genomics company, announces the launch of GBinsight, one of the most advanced next-generation DNA sequencing-based genetic testing and analyses available for complex diseases such as type 2 diabetes (T2D), coronary heart disease (CHD), dyslipidemias and obesity. GBinsight is a simple and
